30 October 2023
Versarien Plc
("Versarien" or the "Company")
Result of General Meeting
Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed. Full details of the resolutions are set out in the Notice of General Meeting dated 12 October 2023 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/
The proxy votes cast were as follows:
Resolution | For |
| Against |
| Abstain |
1 - to sub-divide the Existing Ordinary Shares into New Ordinary Shares and Deferred Shares
| 23,267,848 | 96.07% | 951,505 | 3.93% | 645,931 |
2 - to alter the Articles to allow for the issue of New Deferred Shares
| 23,260,834 | 95.77% | 1,027,547 | 4.23% | 576,903 |
3 - to authorise the Directors to allot shares in the Company
| 22,845,045 | 95.73% | 1,019,150 | 4.27% | 1,001,089 |
4 - to disapply statutory pre-emption rights
| 22,609,443 | 94.75% | 1,253,097 | 5.25% | 1,002,744 |
Share Capital Reorganisation
Following the passing of the resolutions at the General Meeting, each of the Company's 330,779,690 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.1p (the "New Ordinary Shares") and one deferred share of 0.9p ("New Deferred Shares"). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital or on a winding up of the Company.
Admission to AIM and Total Voting Rights
Dealings on AIM in the Existing Ordinary Shares is expected to cease at the close of business on 30 October 2023. Application has been made for the admission of 330,779,690 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on or around 31 October 2023. No application will be made for admission of the New Deferred Shares to trading on AIM nor will any such application be made to any other exchange.
Following Admission, there will be a total of 330,779,690 New Ordinary Shares, with voting rights, in issue. The Company does not hold any shares in treasury. Consequently, 330,779,690 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Company's announcement dated 12 October 2023 and the Circular which was posted to shareholders on the same day.
For further information please contact:
Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer | c/o IFC |
| |
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl | +44 (0)20 3470 0470
|
| |
IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen | +44 (0) 20 3934 6630 |
For further information please see: http://www.versarien.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.